These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34110246)

  • 21. Fluctuation Imaging of LRRK2 Reveals that the G2019S Mutation Alters Spatial and Membrane Dynamics.
    Sanstrum BJ; Goo BMSS; Holden DZY; Delgado DD; Nguyen TPN; Lee KD; James NG
    Molecules; 2020 May; 25(11):. PubMed ID: 32486414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular functions of LRRK2 implicate vesicular trafficking pathways in Parkinson's disease.
    Cookson MR
    Biochem Soc Trans; 2016 Dec; 44(6):1603-1610. PubMed ID: 27913668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exhaustion of mitochondrial and autophagic reserve may contribute to the development of LRRK2
    Juárez-Flores DL; González-Casacuberta I; Ezquerra M; Bañó M; Carmona-Pontaque F; Catalán-García M; Guitart-Mampel M; Rivero JJ; Tobias E; Milisenda JC; Tolosa E; Marti MJ; Fernández-Santiago R; Cardellach F; Morén C; Garrabou G
    J Transl Med; 2018 Jun; 16(1):160. PubMed ID: 29884186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenic LRRK2 compromises the subcellular distribution of lysosomes in a Rab12-RILPL1-dependent manner.
    Ito K; Araki M; Katai Y; Nishimura Y; Imotani S; Inoue H; Ito G; Tomita T
    FASEB J; 2023 May; 37(5):e22930. PubMed ID: 37086089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LRRK2 and RAB7L1 coordinately regulate axonal morphology and lysosome integrity in diverse cellular contexts.
    Kuwahara T; Inoue K; D'Agati VD; Fujimoto T; Eguchi T; Saha S; Wolozin B; Iwatsubo T; Abeliovich A
    Sci Rep; 2016 Jul; 6():29945. PubMed ID: 27424887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurobiology: A pathogenic tug of war.
    Cheng XT; Sheng ZH
    Curr Biol; 2021 May; 31(10):R491-R493. PubMed ID: 34033775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LRRK2 recruitment, activity, and function in organelles.
    Bonet-Ponce L; Cookson MR
    FEBS J; 2022 Nov; 289(22):6871-6890. PubMed ID: 34196120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The V-ATPase-ATG16L1 axis recruits LRRK2 to facilitate the lysosomal stress response.
    Eguchi T; Sakurai M; Wang Y; Saito C; Yoshii G; Wileman T; Mizushima N; Kuwahara T; Iwatsubo T
    J Cell Biol; 2024 Mar; 223(3):. PubMed ID: 38227290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential dynein effectors regulate axonal autophagosome motility in a maturation-dependent pathway.
    Cason SE; Carman PJ; Van Duyne C; Goldsmith J; Dominguez R; Holzbaur ELF
    J Cell Biol; 2021 Jul; 220(7):. PubMed ID: 34014261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interplay between Leucine-Rich Repeat Kinase 2 (LRRK2) and p62/SQSTM-1 in Selective Autophagy.
    Park S; Han S; Choi I; Kim B; Park SP; Joe EH; Suh YH
    PLoS One; 2016; 11(9):e0163029. PubMed ID: 27631370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial clearance and maturation of autophagosomes are compromised in LRRK2 G2019S familial Parkinson's disease patient fibroblasts.
    Korecka JA; Thomas R; Christensen DP; Hinrich AJ; Ferrari EJ; Levy SA; Hastings ML; Hallett PJ; Isacson O
    Hum Mol Genet; 2019 Oct; 28(19):3232-3243. PubMed ID: 31261377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo.
    Albanese F; Mercatelli D; Finetti L; Lamonaca G; Pizzi S; Shimshek DR; Bernacchia G; Morari M
    Neurobiol Dis; 2021 Nov; 159():105487. PubMed ID: 34419621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease.
    Iovino L; Giusti V; Pischedda F; Giusto E; Plotegher N; Marte A; Battisti I; Di Iacovo A; Marku A; Piccoli G; Bandopadhyay R; Perego C; Bonifacino T; Bonanno G; Roseti C; Bossi E; Arrigoni G; Bubacco L; Greggio E; Hilfiker S; Civiero L
    Acta Neuropathol; 2022 Jul; 144(1):81-106. PubMed ID: 35596783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease.
    Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ
    Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease.
    Pang SY; Lo RCN; Ho PW; Liu HF; Chang EES; Leung CT; Malki Y; Choi ZY; Wong WY; Kung MH; Ramsden DB; Ho SL
    Transl Neurodegener; 2022 Jan; 11(1):5. PubMed ID: 35101134
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary Amino Acids Impact LRRK2-Induced Neurodegeneration in Parkinson's Disease Models.
    Chittoor-Vinod VG; Villalobos-Cantor S; Roshak H; Shea K; Abalde-Atristain L; Martin I
    J Neurosci; 2020 Aug; 40(32):6234-6249. PubMed ID: 32605938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy.
    Yakhine-Diop SM; Bravo-San Pedro JM; Gómez-Sánchez R; Pizarro-Estrella E; Rodríguez-Arribas M; Climent V; Aiastui A; López de Munain A; Fuentes JM; González-Polo RA
    Toxicology; 2014 Oct; 324():1-9. PubMed ID: 25017139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation.
    Matikainen-Ankney BA; Kezunovic N; Mesias RE; Tian Y; Williams FM; Huntley GW; Benson DL
    J Neurosci; 2016 Jul; 36(27):7128-41. PubMed ID: 27383589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration.
    Jeong GR; Jang EH; Bae JR; Jun S; Kang HC; Park CH; Shin JH; Yamamoto Y; Tanaka-Yamamoto K; Dawson VL; Dawson TM; Hur EM; Lee BD
    Mol Neurodegener; 2018 Feb; 13(1):8. PubMed ID: 29439717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The LRRK2-RAB axis in regulation of vesicle trafficking and α-synuclein propagation.
    Bae EJ; Lee SJ
    Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165632. PubMed ID: 31812666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.